Shenzhen Development and Reform Commission issued "several measures to promote the High-quality Development of Biopharmaceutical Industry clusters in Shenzhen" and other three policy measures pointed out that medical device enterprises are supported to be included in volume procurement. Enterprises are encouraged to actively participate in the national centralized procurement of medical devices to expand the market. The winning varieties will be subsidized according to 3% of the total purchase amount in that year, the maximum subsidy for a single variety shall not exceed 3 million yuan, and that of a single enterprise shall not exceed 5 million yuan per year.